Societal Impact Of Extending Market Exclusivity For Conventional Drugs

被引：0
|
作者：
Musselwhite, Laura [1 ]
Collingsworth, Bryan [1 ]
机构：
[1] Univ Allied Essential Med, Berkeley, CA 94705 USA
来源：
HEALTH AFFAIRS | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1377/hlthaff.2011.0310
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SOCIETAL AND GOVERNMENTAL PERSPECTIVE OF ORPHAN DRUGS - IS THERE AN IMPACT ON VALUE?
    Kolek, M.
    Pechacek, J.
    Pour, M.
    Novak, J.
    VALUE IN HEALTH, 2023, 26 (06) : S271 - S271
  • [22] Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018
    Rome, Benjamin N.
    Lee, ChangWon C.
    Kesselheim, Aaron S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (02) : 367 - 371
  • [23] Triggering generics market exclusivity
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (11) : 832 - 832
  • [24] Market exclusivity strategies for pharmaceuticals
    Luchetti C.
    Pharmaceutical Medicine, 2009, 23 (2) : 77 - 84
  • [25] THE IMPACT OF GENERIC MARKET EXCLUSIVITY BY THE PATENT-REGISTRATION LINKAGE SYSTEM IN KOREA
    Woo, H.
    Bae, S.
    VALUE IN HEALTH, 2019, 22 : S172 - S172
  • [26] The Impact of Suboxone's Market Exclusivity on Cost of Opioid Use Disorder Treatment
    McGee, Meghan
    Chiu, Kellia
    Moineddin, Rahim
    Sud, Abhimanyu
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (03) : 501 - 510
  • [27] The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment
    Meghan McGee
    Kellia Chiu
    Rahim Moineddin
    Abhimanyu Sud
    Applied Health Economics and Health Policy, 2023, 21 : 501 - 510
  • [28] DYNAMICS OF EU MARKET EXCLUSIVITY: THE IMPACT OF ORPHAN DESIGNATION ON GENERIC OR BIOSIMILAR ENTRY
    Collins, S.
    Patel, B.
    Saada, R.
    Kelly, S.
    VALUE IN HEALTH, 2022, 25 (01) : S144 - S144
  • [29] Variations in Time of Market Exclusivity Among Top-Selling Prescription Drugs in the United States
    Wang, Bo
    Liu, Jun
    Kesselheim, Aaron S.
    JAMA INTERNAL MEDICINE, 2015, 175 (04) : 635 - 637
  • [30] Adalimumab Pricing and Market Exclusivity for Biologics
    Kesselheim, Aaron S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (24): : 2374 - 2374
12345